GXP-PHARMA SUPPORT ApS: Financial statements 2025
CVR: 36033347
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748. The solvency ratio was 29.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 128,518
- Profit/Loss
- DKK -314,498
- Equity
- DKK 58,748
- Total Assets
- DKK 197,965
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 129 t. | -314 t. | 59 t. | 1 |
| 2024 | - | -263 t. | -166 t. | 373 t. | 1 |
| 2023 | - | 361 t. | 367 t. | 1.1 mio. | 1 |
| 2022 | - | 211 t. | -346 t. | 772 t. | 1 |
| 2021 | - | 1.1 mio. | 426 t. | 1.1 mio. | 1 |
How creditworthy is GXP-PHARMA SUPPORT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
On April 30, 2025, the company changed its name from GXP-PHARMA SUPPORT A/S to GXP-PHARMA SUPPORT ApS.
GXP-PHARMA SUPPORT ApS has published its annual report for 2024. Gross profit came to DKK -262,786, and the net result was DKK -166,431.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The board consists of Jan Laursen (chair), Iben Cleveland Laursen and Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.